Drawing for TARGET HEALTH INC

USPTO serial 77506550

TARGET HEALTH INC

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
GOODMAN, WENDY BETH
Law office
TTAB

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 604: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with TARGET HEALTH INC?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Kenneth I. Kohn

KENNETH I. KOHN KOHN & ASSOCIATES, PLLC30500 NORTHWESTERN HIGHWAYSUITE 410FARMINGTON HILLS, MI 48334-3179

Goods and services

ClassDescriptionStatusFirst use
035Data processing services; Providing statistical information for business or commercial purposes; Business auditing services; data processing services in the biostatistics field; Performing statistical analysis for business purposes; Manufacturer representatives in the field of pharmaceuticals; development of business processes for the analysis and implementation of clinical trials dealing with pharmaceutical drug developmentABANDONED—
042Providing online computer database for use in gathering and providing clinical trial data regarding medical and scientific research; Scientific research Product research and development; medical and scientific research services in the field of treatment and diagnosis provided for medical service providers; Technical writing for others; Providing quality assurance services in the field of pharmaceuticals; Medical and scientific research featuring troubleshooting of product and process development problems dealing with safety and regulatory toxicology programs in the field of pharmaceutical drugs; Medical and scientific research, namely, conducting clinical trials; Consultation in the fields of pharmaceutical drug development and conducting clinical trials; consultation in the fields of pharmaceutical drug development, namely, consulting with sponsor, medical, scientific, toxicology, manufacturing and business experts to clearly delineate development requirements and evaluate available and competitive technologies; Product development; Technical writing for others, namely, writing integrated clinical and statistical study reports and other regulatory manuscripts; compiling data in the nature of patient records and patient data via a global computer information network for research purposes in the field of medical science and medical consultancyABANDONED—
045Reviewing standards and practices to assure compliance with medical and pharmaceutical laws and regulations; reviewing standards and practices to assure compliance with US Food and Drug Administration (FDA) laws and regulations; legal consulting services regarding Food and Drug law and regulation compliance, namely, consulting in the preparation of legal negotiations, in the preparation of legal documents and forms required by the FDA, in the preparation of responses to FDA questions and warning letters, and the follow-up with FDA on post application submission questions, in the preparation of meetings with legal counsel; intellectual property licensing in the fields of drug, drug product, pharmaceutical and pharmaceutical productsABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 9, 2010OP.DOPPOSITION DISMISSED NO. 999999—
Mar 19, 2010MAB4ABANDONMENT NOTICE MAILED - INTER PARTES DECISION—
Mar 19, 2010ABN4ABANDONMENT - AFTER INTER PARTES DECISION—
Mar 19, 2010OP.TOPPOSITION TERMINATED NO. 999999—
Mar 19, 2010OP.SOPPOSITION SUSTAINED NO. 999999—
Dec 14, 2009OP.IOPPOSITION INSTITUTED NO. 999999—
Jul 16, 2009ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Jun 16, 2009PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 27, 2009NPUBNOTICE OF PUBLICATION—
May 12, 2009PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
May 11, 2009ALIEASSIGNED TO LIE—
May 11, 2009CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 11, 2009XAECEXAMINER'S AMENDMENT ENTERED—
May 11, 2009GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
May 11, 2009GNEAEXAMINERS AMENDMENT E-MAILED—
May 11, 2009CNEAEXAMINERS AMENDMENT -WRITTEN—
Apr 14, 2009TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 14, 2009CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 14, 2009TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 16, 2008GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 16, 2008GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 16, 2008CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 28, 2008DOCKASSIGNED TO EXAMINER—
Jun 28, 2008MDSCNOTICE OF DESIGN SEARCH CODE MAILED—
Jun 27, 2008NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance